ImmunoGen
IMGN
#2134
Rank
ยฃ6.65 B
Marketcap
ยฃ23.83
Share price
0.00%
Change (1 day)
133.37%
Change (1 year)

ImmunoGen (IMGN) - Total debt

Total debt on the balance sheet as of September 2023 : ยฃ64.35 Million

According to ImmunoGen 's latest financial reports the company's total debt is ยฃ64.35 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

ImmunoGen - Total debt on balance sheet (from 1996 to 2023)

Total debt by year

Year Total debt Change
2022-12-31ยฃ12.6 M-9.44%
2021-12-31ยฃ13.91 M-20.62%
2020-12-31ยฃ17.52 M-14.39%
2019-12-31ยฃ20.47 M1159.12%
2018-12-31ยฃ1.62 M7.2%
2017-12-31ยฃ1.51 M
2016-06-30ยฃ72.49 M
2001-06-30ยฃ0 M-97.79%
2000-06-30ยฃ0.25 M104.76%
1999-06-30ยฃ0.12 M111.97%
1998-06-30ยฃ0.05 M-50.13%
1997-06-30ยฃ0.12 M-95.21%
1996-06-30ยฃ2.5 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
ยฃ34.07 B 52,847.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ36.86 B 57,186.85%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ48.22 B 74,836.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ37.77 B 58,601.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ43.73 B 67,852.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ20.53 B 31,807.98%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
ยฃ34.19 B 53,036.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
ยฃ86.6 M 34.57%๐Ÿ‡บ๐Ÿ‡ธ USA